secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2023-02-24T23:59:59+00:00
Accession:  0001193125-23-048814
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics grants 74,852 RSUs to five named executive officers on Feb 20, 2023
-------------------------------------------------------------------------------

- CEO Waleed Hassanein receives 37,332 RSUs; CFO Stephen Gordon receives 13,075 RSUs.
- Tamer Khayal (13,075 RSUs), Miriam Provost (5,685), and Laura Damme (5,685) also receive grants.
- RSUs vest one-third per year over three years, subject to continued service.
- Compensation Committee also approved form of Inducement RSU Agreement for future grants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312523048814/0001193125-23-048814-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312523048814/d460742d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-048814

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer